Companies: 10,795·Total market cap: $144.5T
Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc.

INBXNASDAQHealthcare● Active
$88.70
+$1.69(+1.94%)
Market Cap$1.3B
P/E Ratio—
52W High$155.29
52W Low$12.8
Overview

Inhibrx Biosciences, Inc. (INBX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · INBX · as of Mar 19, 2026

Latest filing snapshot

1,000,000
+0+0.00%vs prior year

Inhibrx Biosciences, Inc. (INBX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
1,000,000
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$1
Net Income / Employee
$-140
Market Cap
$1.3B

INBX Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-191,000,000+0+0.00%
2025-03-171,000,000——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Inhibrx Biosciences, Inc.
INBX
Inhibrx Biosciences, Inc.YOU
1,000,000#2
CureVac N.V.
CVAC
CureVac N.V.
825#3
Immatics N.V.
IMTX
Immatics N.V.
554#4
Amylyx Pharmaceuticals, Inc.
AMLX
Amylyx Pharmaceuticals, Inc.
123#5
Atai Beckley Inc.
ATAI
Atai Beckley Inc.
99#6
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
62#7
Nektar Therapeutics
NKTR
Nektar Therapeutics
61
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · INBX peer comparison

About INBX employees

INBX Employees · Headcount

Inhibrx Biosciences, Inc. (INBX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Inhibrx Biosciences, Inc. had 1,000,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Inhibrx Biosciences, Inc. employs 1,000,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1, reflecting the company's operational efficiency.

Inhibrx Biosciences, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Inhibrx Biosciences, Inc.'s revenue per employee of $1 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

INBX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Inhibrx Biosciences, Inc. had 1,000,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Inhibrx Biosciences, Inc. employee counthow many employees does Inhibrx Biosciences, Inc. haveINBX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-19